ABSTRACT A multicenter study was conducted to validate Etest tigecycline compared to the
Clinical Laboratory Standards Institute reference broth microdilution and agar dilution …

The current surveillance establishes the activity profile of tigecycline against recent clinical
US isolates of target pathogens. Findings from a distributed surveillance that utilized Etest …

The Tigecycline Evaluation and Surveillance Trial (TEST Program) determined the in vitro
activity of tigecycline over a large population of organisms from geographically diverse sites …

The Tigecycline Evaluation and Surveillance Trial began in 2004 to monitor the in vitro
activity of tigecycline and comparator agents against a global collection of Gram-negative …

MICs to tigecycline and 12 antimicrobials were performed by microdilution method, against
2423 nonduplicate pathogens recently isolated in 17 Greek hospitals. The Food and Drug …

Tigecycline is often one of the few therapeutic options for infections by multidrug-resistant
Gram-negative bacteria. Therefore, accurate MIC testing is critical. Since in many …

Tigecycline is the first glycylcycline antimicrobial in phase III clinical trials. This study
compares the in vitro activity of tigecycline to 12 other predominately broad-spectrum …

Introduction. Tigecycline is one of the important antibiotics available for treating infection
caused by multiple-drug resistant pathogens. However, the conventional AST methods …

Tigecycline activity was evaluated against 11808 pathogens isolated from 30 US medical
centers. Susceptibility testing was performed by reference broth microdilution methods …

Tigecycline is one of the few remaining therapeutic options for extensively drug-resistant
(XDR) Gram-negative bacilli (GNB). MICs of tigecycline to Acinetobacter baumannii have …